Page last updated: 2024-12-05

aceturic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Aceturic acid is a naturally occurring compound found in urine, and is formed by the conjugation of acetic acid with glycine. It can also be synthesized in the laboratory by reacting acetic acid with glycine in the presence of a catalyst. Research has shown that aceturic acid may have potential therapeutic benefits, such as anti-inflammatory and antioxidant properties. It has been studied for its potential role in preventing liver damage and promoting wound healing. The study of aceturic acid is important to understand its physiological role in the body, as well as its potential therapeutic applications.'

aceturic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-acetylglycine : An N-acylglycine where the acyl group is specified as acetyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10972
CHEMBL ID289004
CHEBI ID40410
SCHEMBL ID5876
MeSH IDM0048877

Synonyms (75)

Synonym
EU-0096429
n-acetylglycine
543-24-8
aceturic acid
ethanoylaminoethanoic acid
acetylaminoacetic acid
nsc7605
nsc-7605
acetylglycine
glycine, n-acetyl-
acetylglycocoll
acetamidoacetic acid
(acetylamino)acetic acid
AB-131/40177771
2-acetamidoacetic acid
inchi=1/c4h7no3/c1-3(6)5-2-4(7)8/h2h2,1h3,(h,5,6)(h,7,8
acetylamino-acetic acid
n-acetylglycine, reagentplus(r), 99%
DB02713
A-1250
STK256622
19FC14B9-9BF4-46B1-9A63-D3B6CFB535ED
ac-gly-oh
A0093
CHEMBL289004
chebi:40410 ,
2-acetamidoacetate
AKOS000118774
BMSE000610
n-acetyl-glycine
aceturate
acetamidoacetate
bdbm82197
2-(acetylamino)acetic acid
nsc 7605
unii-u2ut4677kr
ai3-17738
u2ut4677kr ,
einecs 208-839-6
FT-0629819
AB00351
AB00374931-02
aceturic acid [mi]
AB00374931-04
AM81782
acetyl-glycine
SCHEMBL5876
n-acetyl glycine
acetyl-glycin
DTXSID2043793
n-acetylglycine sodium salt
S3098
ch3conhch2cooh
acetyl glycine
AC-24104
mfcd00004275
Z85886676
F0921-6976
n-acetylglycine, vetec(tm) reagent grade, 98%
ethanoylaminoethanoate
ac gly
15n-acetylglycine a-radical
HY-Y0069
SY013515
CS-W020121
AS-12785
doi:10.14272/okjirpaqvshgfk-uhfffaoysa-n.1
10.14272/OKJIRPAQVSHGFK-UHFFFAOYSA-N.1
Q15634040
BBL020087
AC8343
NCGC00320093-01
n-acetylglycine acetylglycine acetamidoacetic acid
n-acetylglycine-d5
EN300-18561
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
N-acetyl-amino acidAn N-acyl-amino acid that has acetyl as the acyl group.
N-acylglycineAn N-acyl-amino acid in which amino acid specified is glycine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
heme biosynthetic processDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
protoporphyrinogen IX biosynthetic processDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
heme biosynthetic processDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
tetrapyrrole biosynthetic processDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
peptide amidationPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
response to zinc ionPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
fatty acid primary amide biosynthetic processPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
magnesium ion bindingDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
porphobilinogen synthase activityDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
zinc ion bindingDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
lyase activityDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
metal ion bindingDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
peptidylglycine monooxygenase activityPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
peptidylamidoglycolate lyase activityPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
copper ion bindingPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
calcium ion bindingPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
protein bindingPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
zinc ion bindingPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
L-ascorbic acid bindingPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
cytosolDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
cytosolDelta-aminolevulinic acid dehydrataseEscherichia coli K-12
membranePeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
transport vesicle membranePeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
secretory granule membranePeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
extracellular exosomePeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
extracellular regionPeptidyl-glycine alpha-amidating monooxygenaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID717276Binding affinity to PAM in human DMS53 cells after 2 hrs by HPLC analysis2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency.
AID388273Ratio of Vm(app) to Km(app) for rat recombinant peptidylglycine alpha-amidating monooxygenase2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
AID122913Inhibition of [125I]ristocetin binding to micrococcus luteus cells.1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Inhibition of 125I-labeled ristocetin binding to Micrococcus luteus cells by the peptides related to bacterial cell wall mucopeptide precursors: quantitative structure-activity relationships.
AID717275Binding affinity to secreted PAM in human DMS53 cell culture medium after 2 hrs by HPLC analysis2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency.
AID388272Activity of rat recombinant peptidylglycine alpha-amidating monooxygenase assessed as stimulation of oxygen consumption2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
AID498706Inhibition of beta lactamase CTX-M assessed as hydrolysis of beta lactam up to 5 mM by spectrometry analysis2009Nature chemical biology, May, Volume: 5, Issue:5
Molecular docking and ligand specificity in fragment-based inhibitor discovery.
AID26351pKa value was determined1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
Methotrexate analogues. 16. Importance of the side-chain amide carbonyl group as a structural determinant of biological activity.
AID227556Affinity for Vancomycin (Exp II)1999Journal of medicinal chemistry, Nov-04, Volume: 42, Issue:22
Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding.
AID388274Ratio of Vm(app) to Km(app) for rat recombinant peptidylglycine alpha-amidating monooxygenase relative to hippuric acid2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
AID1799605PBGS Assay from Article 10.1002/1439-7633(20010504)2: \\Inhibition studies of porphobilinogen synthase from Escherichia coli differentiating between the two recognition sites.\\2001Chembiochem : a European journal of chemical biology, May-04, Volume: 2, Issue:5
Inhibition studies of porphobilinogen synthase from Escherichia coli differentiating between the two recognition sites.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (14.63)18.7374
1990's8 (19.51)18.2507
2000's16 (39.02)29.6817
2010's10 (24.39)24.3611
2020's1 (2.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.19 (24.57)
Research Supply Index3.76 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.44%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (97.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]